Neural Analytics Inc. Announces The Appointment Of Dr. Neil A. Martin As Chief Medical Officer

LOS ANGELES--(BUSINESS WIRE)--Neural Analytics, a medical device company focusing on developing devices and services to measure, diagnose and track brain health and concussions, announced the appointment of Dr. Neil A. Martin as chief medical officer.

As the chairman and W. Eugene Stern Professor in Neurosurgery in the UCLA Department of Neurosurgery, Dr. Martin comes to Neural Analytics with extensive experience in research and treatment of brain injury and neurovascular disorders, including aneurysm, stroke and arteriovenous malformation.

Suggested Articles

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.